Status:
COMPLETED
Randomized Controlled Trial to Study the Outcome of Intravenous Phosphate Supplementation in Live Donors Undergoing Hepatectomy for Living Donor Liver Transplantation (LDLT)
Lead Sponsor:
Institute of Liver and Biliary Sciences, India
Conditions:
Complication, Postoperative
Regeneration Liver
Eligibility:
All Genders
18-50 years
Phase:
PHASE4
Brief Summary
In this study, we aim to analyse the effect of phosphate supplementation on donors undergoing partial hepatectomy for LDLT. In Group A, we are going to supplement phosphate in donors postoperatively f...
Eligibility Criteria
Inclusion
- All donors evaluated as per institutional protocol for donor hepatectomy and found fit
- Those who consent.
Exclusion
- Patients refusing to consent for inclusion in the study.
- Minor hepatectomy
- Those who develop profound hypophosphatemia in the control group
Key Trial Info
Start Date :
January 21 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 24 2021
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04026438
Start Date
January 21 2019
End Date
February 24 2021
Last Update
November 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Liver and Biliary Sciences
New Delhi, India, 110070